Archives
Influenza Hemagglutinin (HA) Peptide: High-Purity Tag for...
Influenza Hemagglutinin (HA) Peptide: High-Purity Tag for Protein Detection and Purification
Executive Summary: The Influenza Hemagglutinin (HA) Peptide (sequence: YPYDVPDYA) is a synthetic, nine-amino acid tag employed for immunodetection and purification of HA-tagged fusion proteins in molecular biology research [APExBIO product page]. The HA tag peptide achieves ≥98% purity as confirmed by HPLC and mass spectrometry, ensuring minimal background and high reproducibility. Its solubility exceeds 55.1 mg/mL in DMSO, 100.4 mg/mL in ethanol, and 46.2 mg/mL in water, allowing for flexible use in diverse experimental conditions. The peptide functions by competitively binding to anti-HA antibodies, facilitating the elution of HA-tagged proteins during immunoprecipitation workflows. Peer-reviewed literature confirms the specificity and efficiency of this tag for protein-protein interaction studies and translational workflows (Dong et al., 2025).
Biological Rationale
Epitope tagging is a core strategy in molecular biology for studying protein expression, localization, and interactions [LabPE, 2024]. The Influenza Hemagglutinin (HA) Peptide is derived from the human influenza virus hemagglutinin protein's epitope region, specifically residues 98–106 (YPYDVPDYA) (Dong et al., 2025). This region is recognized by high-affinity monoclonal anti-HA antibodies, enabling selective detection and purification of HA-tagged proteins. The HA tag system is widely adopted due to its minimal size, low immunogenicity, and absence of cross-reactivity with endogenous mammalian proteins. This contrasts with larger tags or those prone to proteolytic cleavage. The high purity and validation of the APExBIO Influenza Hemagglutinin (HA) Peptide (A6004) further ensure reproducibility across research laboratories [Olaparib.net].
Mechanism of Action of Influenza Hemagglutinin (HA) Peptide
The HA tag peptide operates through a competitive binding mechanism. It mimics the epitope recognized by anti-HA antibodies. When introduced during immunoprecipitation, the HA peptide binds to the antibody’s antigen-binding site. This disrupts the antibody-HA fusion protein interaction and enables specific elution of the HA-tagged protein from affinity matrices [Influenza Hemagglutinin (HA) Peptide: Precision Tag for A..., 2024]. The high solubility of the peptide ensures efficient competition and rapid elution kinetics. The mechanism relies on the antibody’s affinity for the YPYDVPDYA sequence and does not interfere with the structure or function of the fusion protein, making it suitable for downstream analysis, including mass spectrometry and enzyme assays. This process is applicable to immunoprecipitation protocols employing both magnetic beads and conventional antibody-agarose systems.
Evidence & Benchmarks
- The HA tag peptide enables the isolation of HA-tagged PRMT5 proteins in colorectal cancer cell lines, facilitating mechanistic studies of E3 ligase-mediated ubiquitination (Dong et al., 2025, DOI).
- Purity of the commercial Influenza Hemagglutinin (HA) Peptide (A6004, APExBIO) exceeds 98%, as verified by independent HPLC and MS analyses (APExBIO).
- Solubility benchmarks: ≥55.1 mg/mL in DMSO, ≥100.4 mg/mL in ethanol, and ≥46.2 mg/mL in water at room temperature, supporting diverse buffer compatibility (Olaparib.net).
- HA peptide-based elution enables the recovery of functionally intact protein complexes in co-immunoprecipitation, facilitating downstream protein-protein interaction studies (Influenza Hemagglutinin (HA) Peptide: Precision Tag for A...).
- Use of the HA peptide tag system is considered the gold standard in exosome biogenesis, protein interactomics, and translational research workflows, surpassing several alternative tags in reproducibility and specificity (gdc-0449.com).
Applications, Limits & Misconceptions
The Influenza Hemagglutinin (HA) Peptide is routinely used for:
- Elution of HA-tagged fusion proteins from immunoprecipitation matrices.
- Detection of HA-tagged constructs in western blot, immunofluorescence, and ELISA assays.
- Protein-protein interaction and ubiquitination studies, as exemplified in mechanistic cancer biology (Dong et al., 2025).
- Quality control of tagged protein purity and yield.
This article extends prior coverage by providing updated quantitative benchmarks and clarifies product-specific handling, as contrasted with LabPE's guide, which focuses on general troubleshooting strategies.
Common Pitfalls or Misconceptions
- The HA tag peptide does not function as a protease or enzymatic cleavage site; it is exclusively an epitope tag for antibody recognition.
- It is not suitable for direct in vivo applications in animal models due to rapid peptide degradation and potential immunogenicity.
- Excess peptide concentrations may competitively inhibit antibody binding during detection steps, resulting in reduced sensitivity.
- HA tag does not alter the native folding or function of the fusion protein, but improper tag placement can interfere with protein function.
- The peptide is not a universal tag—antibody cross-reactivity must be empirically validated for each species and antibody clone used.
Workflow Integration & Parameters
The APExBIO Influenza Hemagglutinin (HA) Peptide (A6004) is supplied as a lyophilized powder with ≥98% purity. For optimal performance, dissolve the peptide in DMSO (≥55.1 mg/mL), ethanol (≥100.4 mg/mL), or water (≥46.2 mg/mL) at room temperature. Store lyophilized peptide at -20°C, desiccated. Avoid prolonged storage of peptide solutions; prepare aliquots to minimize freeze-thaw cycles.
During immunoprecipitation, add the HA peptide to the resin at concentrations ranging from 0.5–2 mg/mL, incubate at 4°C for 30–60 minutes, and collect the eluted fraction. This protocol is compatible with both magnetic bead and traditional agarose-based systems. The tag’s efficiency has been validated in workflows involving NEDD4L-PRMT5 ubiquitination studies in colorectal cancer models (Dong et al., 2025). Compared to previous reviews [Influenza Hemagglutinin (HA) Peptide: Precision Tag for A...], this section details precise solubilization parameters and storage guidance for the A6004 product.
Conclusion & Outlook
The Influenza Hemagglutinin (HA) Peptide (A6004, APExBIO) is a rigorously validated molecular tool for protein detection and purification workflows. Its high purity, robust solubility, and validated competitive binding mechanism enable precise immunoprecipitation and protein-protein interaction studies. As highlighted in translational research applications [Translational Frontiers], the HA tag system continues to set benchmarks for specificity and reproducibility. Future developments may optimize tag-antibody pairs for in vivo compatibility and multiplexed detection, but the current HA peptide standard remains indispensable for advanced molecular biology research. For detailed specifications and ordering, refer to the official Influenza Hemagglutinin (HA) Peptide product page.